Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies

被引:78
作者
Ben-Menachem, E [1 ]
Kyllerman, M
Marklund, S
机构
[1] Gothenburg Univ, Sahlgrens Hosp, Dept Neurol, S-41345 Gothenburg, Sweden
[2] Gothenburg Univ, Sahlgrens Hosp, Dept Pediat Neuropediat, S-41345 Gothenburg, Sweden
[3] Umea Univ Hosp, S-90185 Umea, Sweden
关键词
superoxide dismutase; glutathione; progressive myoclonus epilepsy; antioxidant therapy;
D O I
10.1016/S0920-1211(00)00096-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Progressive myoclonic epilepsies (EPM) are difficult to treat and refractory to most antiepileptic drugs. Besides epilepsy, EPMs also involve continuous neurological deterioration. Oxidative stress is thought to be an important factor in this process. We therefore analyzed a series of antioxidant enzymes in the blood of patients and compared with healthy age matched controls. In addition patients were given high doses of N-acetylcysteine (NAC), a glutathione percursor to determine if symptoms of EPM would improve. Five patients, four with EPM 1 (Unvericht-Lundborg disease) and one patient with EPM2 (Lafora body disease) were treated with 6 g/day of NAG. Before treatment, plasma samples were analyzed for glutathione peroxidase activity, catalase activity, extracellular superoxide dismutase (SOD) and CuZn-SOD and compared with the controls. Erythrocyte CuZn-SOD was significantly lower in the EPM patients compared to controls. NAC improved markedly and stabilized the neurological symptoms in patients with EPM 1 but had a doubtful effect in the patient with EPM 2. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 23 条
[1]   BALTIC MYOCLONUS EPILEPSY - HEREDITARY DISORDER OF CHILDHOOD MADE WORSE BY PHENYTOIN [J].
ELDRIDGE, R ;
STERN, R ;
IIVANAINEN, M ;
KOERBER, T ;
WILDER, BJ .
LANCET, 1983, 2 (8354) :838-842
[2]   FREE-RADICALS IN BRAIN METABOLISM AND PATHOLOGY [J].
EVANS, PH .
BRITISH MEDICAL BULLETIN, 1993, 49 (03) :577-587
[3]   LEVELS OF SELENIUM IN PLASMA AND GLUTATHIONE-PEROXIDASE IN ERYTHROCYTES AND THE RISK OF BREAST-CANCER - A CASE-CONTROL STUDY [J].
HARDELL, L ;
DANELL, M ;
ANGQVIST, CA ;
MARKLUND, SL ;
FREDRIKSSON, M ;
ZAKARI, AL ;
KJELLGREN, A .
BIOLOGICAL TRACE ELEMENT RESEARCH, 1993, 36 (02) :99-108
[4]   Treatment of four siblings with progressive myoclonus epilepsy of the Unverricht-Lundborg type with N-acetylcysteine [J].
Hurd, RW ;
Wilder, BJ ;
Helveston, WR ;
Uthman, BM .
NEUROLOGY, 1996, 47 (05) :1264-1268
[5]  
HURD RW, 1993, EPILEPSIA S2, V34, P14
[6]   PLASMA-CLEARANCE OF HUMAN EXTRACELLULAR-SUPEROXIDE DISMUTASE-C IN RABBITS [J].
KARLSSON, K ;
MARKLUND, SL .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (03) :762-766
[7]   CLINICAL AND NEUROPHYSIOLOGICAL DEVELOPMENT OF UNVERRICHT-LUNDBORG DISEASE IN 4 SWEDISH SIBLINGS [J].
KYLLERMAN, M ;
SOMMERFELT, K ;
HEDSTROM, A ;
WENNERGREN, G ;
HOLMGREN, D .
EPILEPSIA, 1991, 32 (06) :900-909
[8]   Unstable insertion in the 5' flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1 [J].
Lafreniere, RG ;
Rochefort, DL ;
Chretien, N ;
Rommens, JM ;
Cochius, JI ;
Kalviainen, R ;
Nousiainen, U ;
Patry, G ;
Farrell, K ;
Soderfeldt, B ;
Federico, A ;
Hale, BR ;
Cossio, OH ;
Sorensen, T ;
Pouliot, MA ;
Kmiec, T ;
Uldall, P ;
Janszky, J ;
Pranzatelli, MR ;
Andermann, F ;
Andermann, E ;
Rouleau, GA .
NATURE GENETICS, 1997, 15 (03) :298-302
[9]   LINKAGE STUDIES IN PROGRESSIVE MYOCLONUS EPILEPSY - UNVERRICHT-LUNDBORG AND LAFORAS DISEASES [J].
LEHESJOKI, AE ;
KOSKINIEMI, M ;
PANDOLFO, M ;
ANTONELLI, A ;
KYLLERMAN, M ;
WAHLSTROM, J ;
NERGARDH, A ;
BURMEISTER, M ;
SISTONEN, P ;
NORIO, R ;
DELACHAPELLE, A .
NEUROLOGY, 1992, 42 (08) :1545-1550
[10]   ARCHITECTURE AND ANATOMY OF THE CHROMOSOMAL LOCUS IN HUMAN CHROMOSOME-21 ENCODING THE CU/ZN SUPEROXIDE-DISMUTASE [J].
LEVANON, D ;
LIEMANHURWITZ, J ;
DAFNI, N ;
WIGDERSON, M ;
SHERMAN, L ;
BERNSTEIN, Y ;
LAVERRUDICH, Z ;
DANCIGER, E ;
STEIN, O ;
GRONER, Y .
EMBO JOURNAL, 1985, 4 (01) :77-84